Navidea Biopharmaceuticals Inc

ASE:NAVB   1:01:33 PM EDT
-0.07 (-5.74%)
Earnings Announcements

Navidea Biopharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/10/2021 21:09 GMT
Navidea Biopharmaceuticals Inc (NAVB) - Navidea Biopharmaceuticals Reports Third Quarter 2021 Financial Results.
Revenue is expected to be $1.8 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.